Curcumin was developed as a novel inhibitor of the STAT3 pathway where treatment with curcumin suppressed the expression of phosphorylated STAT3 in a dose-dependent manner in normal broncho epithelial cells (AALE) and human lung adenocarcinoma cells (H441). This evidence concerns the gene STAT3 and lung adenocarcinoma.